Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 62 Vincristine 45 Doxorubicin 43 Etoposide 42 Rituximab 37 Prednisone 31 Filgrastim 31 Biopsy 27 Peripheral Blood Stem Cell Transplantation 25 Cytarabine 24 Radiotherapy 22 fludarabine phosphate 19 Specimen Handling 19 Methotrexate 19 Magnetic Resonance Spectroscopy 18 Prednisolone 17 Melphalan 16 Ifosfamide 14 Dexamethasone 14 Bleomycin 13 Leucovorin 12 Cyclosporine 12 Carmustine 12 sargramostim 11 Cisplatin 10 Vinblastine 8 Chlorambucil 8 Busulfan 8 fludarabine 7 Nivolumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Lymphoma × imetelstat × Clear all

NCT01568632 2012-11-21

Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡